Dysregulation of epigenetic, biological and mitotic age in the context of biologic drug treatment and phototherapy in plaque psoriasis patients
J Eur Acad Dermatol Venereol
.
2024 Oct;38(10):e883-e886.
doi: 10.1111/jdv.19978.
Epub 2024 Apr 15.
Authors
Richie Jeremian
1
2
,
Yuliya Lytvyn
3
,
Rayyan Fotovati
1
,
Kaiyang Li
1
2
,
Alexandra Malinowski
4
,
Muskaan Sachdeva
3
,
Carolyn Jack
1
2
,
Melinda Gooderham
5
,
David O Croitoru
3
,
Jensen Yeung
3
,
Vincent Piguet
3
6
Affiliations
1
Faculty of Medicine and Health Sciences, McGill University, Montréal, Quebec, Canada.
2
McGill University Health Centre (MUHC) Center of Excellence for Atopic Dermatitis, Montréal, Quebec, Canada.
3
Division of Dermatology, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
4
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
5
SKiN Centre for Dermatology, Peterborough, Ontario, Canada.
6
Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada.
PMID:
38619335
DOI:
10.1111/jdv.19978
No abstract available
Publication types
Letter
MeSH terms
Adult
Biological Products / therapeutic use
Epigenesis, Genetic*
Female
Humans
Male
Middle Aged
Phototherapy* / methods
Psoriasis* / drug therapy
Psoriasis* / therapy
Substances
Biological Products
Grants and funding
"Canadian Association of Psoriasis Patients, Canadian Institutes of Health Research: Institute of Musculoskeletal Health and Arthritis" (CAPP-CIHR-IMHA) Studentship